about
An autoinflammatory disease with deficiency of the interleukin-1-receptor antagonistMagnetic resonance imaging and computed tomography in emergency assessment of patients with suspected acute stroke: a prospective comparisonSLC26A4 genotypes and phenotypes associated with enlargement of the vestibular aqueductChimeric negative regulation of p14ARF and TBX1 by a t(9;22) translocation associated with melanoma, deafness, and DNA repair deficiencyLong-term natural history of neurofibromatosis Type 2-associated intracranial tumorsNeurofibromatosis type 2.Long-term stability after multilevel cervical laminectomy for spinal cord tumor resection in von Hippel-Lindau disease.Pathophysiology of primary spinal syringomyeliaSLC26A4 genotype, but not cochlear radiologic structure, is correlated with hearing loss in ears with an enlarged vestibular aqueduct.Effect of ependymal and pial surfaces on convection-enhanced deliveryMechanisms of hearing loss in neurofibromatosis type 2.Cryopyrin-associated periodic syndromes: otolaryngologic and audiologic manifestationsAltered language processing in autosomal dominant partial epilepsy with auditory featuresIron accumulation in deep cortical layers accounts for MRI signal abnormalities in ALS: correlating 7 tesla MRI and pathology.Phase II trial of single-agent bevacizumab followed by bevacizumab plus irinotecan at tumor progression in recurrent glioblastomaA phase I/II trial of enzastaurin in patients with recurrent high-grade gliomasPhase 2 trial of talampanel, a glutamate receptor inhibitor, for adults with recurrent malignant gliomas.Quantitative assessment of susceptibility-weighted imaging processing methodsVariable expressivity of FGF3 mutations associated with deafness and LAMM syndromeTreatment of neurocysticercosis: current status and future research needsRapid, high-resolution, whole-brain, susceptibility-based MRI of multiple sclerosisSurgery versus watchful waiting in patients with craniofacial fibrous dysplasia--a meta-analysisOptic neuropathy in McCune-Albright syndrome: effects of early diagnosis and treatment of growth hormone excessComparison of MRI and CT for detection of acute intracerebral hemorrhage.A 24-month open-label study of canakinumab in neonatal-onset multisystem inflammatory disease.Effects of VHL deficiency on endolymphatic duct and sac.Tumors of the endolymphatic sac in von Hippel-Lindau disease.Improved measurement of brain deformation during mild head acceleration using a novel tagged MRI sequence.PET attenuation correction using synthetic CT from ultrashort echo-time MR imaging.Effect of foreknowledge on neural activity of primary "go" responses relates to response stopping and switching.Artifactual microhemorrhage generated by susceptibility weighted image processing.Surgical management of lumbosacral nerve root hemangioblastomas in von Hippel-Lindau syndrome.Sacral hemangioblastoma in a patient with von Hippel-Lindau disease. Case report and review of the literature.Validation of dynamic contrast-enhanced magnetic resonance imaging-derived vascular permeability measurements using quantitative autoradiography in the RG2 rat brain tumor model.Fast T1 mapping determined using incomplete inversion recovery look-locker 3D balanced SSFP acquisition and a simple two-parameter model fit.User-friendly software for the analysis of brain lesions (ABLe).Reduced scan time three-dimensional FLAIR using modulated inversion and repetition time.Sustained response and prevention of damage progression in patients with neonatal-onset multisystem inflammatory disease treated with anakinra: a cohort study to determine three- and five-year outcomesNeurologic manifestations of von Hippel-Lindau diseaseCerebrovascular disease associated with sickle cell pulmonary hypertension.
P50
Q24606097-ABE13745-6BAB-4B81-A871-467F58FC4B65Q24676950-744A3121-8A8A-4F65-B491-264DE659D185Q27010177-5DF36C59-CC91-415A-A0A3-B46F6C4A7046Q28290365-922865EB-EDE1-42DA-852A-123F4A1F4735Q30391370-3E8AACD6-B331-4114-B4B7-4E5A52359F0EQ30391375-E685DC38-8699-4DFE-8FDA-C9FA76FB9FC8Q30408620-5AF44F18-963A-473A-8376-5EC37EB6D34BQ30416967-00C3ED23-135C-434A-AE23-4AE2D82B770EQ30433364-99C82915-0C50-4D3B-A5CA-CDDD0AD9F3C1Q30438101-8EAE36DD-0516-435D-843C-440943076FF3Q30462725-C3938CAE-F8F5-4F76-B53A-F0CF180B4F9CQ30465378-5F38921C-619D-4117-A768-4D310284AB62Q30484710-FCBE838B-E821-462F-9AF4-C9C8BB451AEBQ31058247-10D26B88-A75C-438C-8660-63213EBD0D80Q33382596-76F11791-C550-490B-A124-3AF39DF20F72Q33388240-8E731900-5D37-4D51-BC60-1C54904E5077Q33759231-8AE38E2B-D187-468D-AEB2-24C03D5F8722Q33763843-FA42A22E-00DF-49C0-A0D8-A00691B88AC8Q33816386-173EC4B8-9683-44EB-9C19-D7CC63E263CEQ34071278-34511A55-94C1-4D0C-BB01-06E7F4796B72Q34203136-588FD606-E378-4F99-A4AB-19222A36F759Q34220958-46CF0E93-1F28-436A-8225-B6B5988AE9B8Q34307900-56A9A5C5-FF8E-4680-89C3-BBB9F53E1732Q34360419-B40402FC-66E4-41A9-98D5-2E31EBF39641Q34423486-368D07DF-2F3F-4493-9A25-435E4C7A5C38Q34472041-EB38B417-DAC1-4358-B460-1C5F0F88CE5CQ34548525-FF2F6D9E-98DE-405C-B0EF-772F81C44F2EQ34622944-0FE1112C-DFD0-4125-B35F-DAED21A164B6Q34624446-690ECECC-B2B7-4157-BEA5-347A3061D912Q35047800-BAAA436C-4236-4C21-8864-FC333369F7EBQ35107014-4A761910-EB9E-49F8-A876-1D0870842FAFQ35177244-E7B6B7C5-FAEC-4244-9C1D-174037797817Q35878988-24EE7FE4-5434-4B98-9E5D-FE6ADB2CD3E2Q35925126-5BC300C9-B051-4320-AE0A-28617AC3D23BQ35931455-0C02DC44-2194-4BFD-B9A6-BBAAC3F16050Q36016368-911F9EF0-3A5F-4574-97B3-DFE7DAEEE4A0Q36104119-EAFC155A-91C0-4274-B92A-775A52654FFAQ36327767-86460936-85BE-4F5F-8481-C17DD5A03D3DQ36365767-D8E8D33A-A8E2-49BA-8723-E803F64457D3Q36392798-3C1C985D-AD15-4C19-ABA4-E371FF4C8EA0
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
John A Butman
@nl
John A Butman
@sl
John A. Butman
@en
John A. Butman
@es
type
label
John A Butman
@nl
John A Butman
@sl
John A. Butman
@en
John A. Butman
@es
prefLabel
John A Butman
@nl
John A Butman
@sl
John A. Butman
@en
John A. Butman
@es
P1053
J-2780-2013
P106
P1153
6701440174
P2038
John_Butman
P21
P2456
P2798
P31
P3829
P3835
john-butman2
P496
0000-0002-1547-9195